Plasmodium falciparum persists in the placenta after three days' treatment with quinine

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 91, Issue 4, 1997, Pages 431-

  Sartelet, H ^a,c   Milko Sartelet, I ^a   Garraud, O ^b   Picot, S ^c  

^a HÔPITAL PRINCIPAL DE DAKAR   (Senegal)

^b INSTITUT PASTEUR DE DAKAR   (Senegal)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Malaria; Placental infection; Plasmodium falciparum; Quinine

Indexed keywords

ANTIMALARIAL AGENT; CELL ADHESION MOLECULE; CHLOROQUINE; QUININE;

ADULT; ARTICLE; CAPILLARY; CASE REPORT; DISEASE TRANSMISSION; ERYTHROCYTE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALARIA FALCIPARUM; ORAL DRUG ADMINISTRATION; PLACENTA; PLASMODIUM FALCIPARUM; PREGNANCY; SEASONAL VARIATION; SENEGAL;

CINCHONA PUBESCENS; PLASMODIUM FALCIPARUM;

EID: 0030764046     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(97)90269-8     Document Type: Article

References (4)

1. Fried, M. & Duffy, P. E. (1996). Adherence of Plasmodium falciparum to chondroitin sulphate A in human placenta. Science, 272, 1502-1504.
2. Rogier, C., Brau, R., Tall, A., Cisse, B. & Trape, J. F. (1996). Reducing the oral quinine-quinidine-cinchonine (Quinimax®) treatment of uncomplicated malaria to three days does not increase the recurrence of attacks among children living in a highly endemic area of Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene, 90, 175-178.
3. Testa, J., Awodabon, J., Lagarde, N., Olivier, T. & Delmont, J. (1991). Intérêt de l'apposition placentaire comme marqueur épidémiologique du paludisme. Bulletin de la Société de Pathologie Exotique, 84, 473-479.
4. WHO (1990). Practical Chemotherapy of Malaria. Geneva: World Health Organization, Technical Report series, no. 805.